SCHEMBL139209

SCHEMBL139209

c1ccc(-c2ccon2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.51
RAB9A P51151 6/20 0.50
NPC1 O15118 5/20 0.50
KDM4E B2RXH2 3/20 0.50
MAPT P10636 1/20 0.50
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP19A1 P11511 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NOTUM Q6P988 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
ADORA2A P29274 2/20 0.39
ASIC3 Q9UHC3 1/20 0.39
AURKA O14965 1/20 0.39
HSP90AA1 P07900 1/20 0.39
PRKACA P17612 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8524430 0.98 MDM2 (0.50) MDM2RAB9ANPC1KDM4EMAPT
SCHEMBL2409954 0.95 MDM2 (0.49) MDM2RAB9ANPC1KDM4EMAPT
SCHEMBL27913095 0.93 MDM2 (0.47) MDM2RAB9ANPC1KDM4EMAPT
SCHEMBL16175776 0.88 MDM2 (0.44) MDM2RAB9ANPC1KDM4EMAPT
Carbamic Acid SCHEMBL29154176 0.88 MDM2 (0.44) MDM2RAB9ANPC1KDM4EMAPT
SCHEMBL4059081 0.87 CYP1A2 (0.57) MDM2RAB9ANPC1KDM4EMAPT
Tetrahydrofuran SCHEMBL27422789 0.86 MDM2 (0.43) MDM2RAB9ANPC1KDM4EMAPT
SCHEMBL27402049 0.85 MDM2 (0.45) MDM2RAB9ANPC1KDM4EMAPT
Oxazole SCHEMBL27278480 0.83 RAB9A (0.43) MDM2RAB9ANPC1KDM4EMAPT
SCHEMBL5947673 0.82 CYP1A2 (0.54) RAB9ANPC1CYP1A2CYP2D6CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 607 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3356387-B1 ANTIMICROBIAL POLYMYXIN DERIVATIVE COMPOUNDS UNIV MONASH (AU) 2024-06-26 EP claimed
CN-113272292-B (2, 5-dioxopyrrolidin-1-yl) (phenyl) -acetamide derivatives and their use in the treatment of neurological diseases 雅盖隆大学 2024-04-12 CN claimed
CN-111253384-B Preparation and application of 3-isoxazole methoxy pyrazole-5-amide containing substituted phenyl isoxazole unit 南通大学 2023-04-07 CN claimed
WO-2022245085-A1 HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2022-11-24 WO claimed
CN-111320715-B Ultrahigh molecular weight polyolefin catalyst, and preparation method and application thereof 叶平山 2022-10-04 CN claimed
CN-108350034-B Antimicrobial polymyxin derived compounds 莫纳什大学 2022-03-11 CN claimed
US-20220073461-A1 (2,5-DIOXOPYRROLIDIN-1-YL)(PHENYL)-ACETAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES WARSZAWSKI UNIWERSYTET MEDYCZNY (PL) 2022-03-10 US claimed
EP-3908580-A1 (2,5-DIOXOPYRROLIDIN-1-YL)(PHENYL)-ACETAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES UNIWERSYTET JAGIELLONSKI (PL) 2021-11-17 EP claimed
CN-113272292-A (2, 5-dioxopyrrolidin-1-yl) (phenyl) -acetamide derivatives and their use in the treatment of neurological diseases 雅盖隆大学 2021-08-17 CN claimed
CN-105263329-B Methods and compositions for weed control 孟山都技术公司 2020-09-18 CN claimed
US-20090325896-A1 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS IBRAHIM PRABHA 2009-12-31 US claimed
CN-100409748-C Substituted phenyl-isoxazole herbicide WANG ZHENGQUAN (CN) 2008-08-13 CN claimed
CN-1939127-A Substituted phenyl-isoxazole herbicide WANG ZHENGQUAN (CN) 2007-04-04 CN claimed
US-20060287275-A1 Partial and full agonists of A1 adenosine receptors IBRAHIM PRABHA 2006-12-21 US claimed
US-6846934-B2 Photochromic diarylethene substituted with isoxazole group KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-01-25 US claimed
US-20030118924-A1 Diarylethene derivatives and photochromic thin film prepared using the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 2003-06-26 US claimed
US-20030086978-A1 Thermal stability, transparency, and photochromic property; to be used as optical materials such as an optical recording material, an optical switch, and the like KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 2003-05-08 US claimed
US-20020188043-A1 Photochromic diarylethene substituted with isoxazole group KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2002-12-12 US claimed
CN-1068567-A NEW HERBICIDES RHONE POULENC AGRICULTURE (GB) 1993-02-03 CN claimed
US-3939167-A 3-(2-Methylthio-2-tertiary aminoacetyl)-5-phenylisoxazoles SHIONOGI & CO., LTD. (JA) 1976-02-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325896-A1 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS ADORA1, ADORA2A, ADORA3 MDM2 2474/4885RAB9A 2024/4885NPC1 400/4885
US-20060287275-A1 Partial and full agonists of A1 adenosine receptors ADORA1, ADORA2A, ADORA3 MDM2 2474/4885RAB9A 2024/4885NPC1 400/4885
US-20030118924-A1 Diarylethene derivatives and photochromic thin film prepared using the same DIAPH1, CRY1, CRY2 MDM2 516/4885RAB9A 705/4885NPC1 1629/4885
US-20220073461-A1 (2,5-DIOXOPYRROLIDIN-1-YL)(PHENYL)-ACETAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES TRPV5, P2RX5, TRPV1 MDM2 4692/4885RAB9A 3675/4885NPC1 1107/4885
US-20030086978-A1 Thermal stability, transparency, and photochromic property; to be used as optical materials such as an optical recording material, an optical switch, and the like CCNE2, CRYZ, TRRAP MDM2 468/4885RAB9A 2072/4885NPC1 1067/4885
US-20020188043-A1 Photochromic diarylethene substituted with isoxazole group CRY1, NR2E3, DDT MDM2 3747/4885RAB9A 1531/4885NPC1 4822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.